UCLA study shows how interferon-gamma guides response to cancer immunotherapy

(University of California - Los Angeles Health Sciences) UCLA researchers shed light on how interferon-gamma (IFN-y) guides the treatment response in people with advanced melanoma who are treated with one of the leading immunotherapies -- immune checkpoint blockade.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news